Antares Pharma (ATRS) Misses Q3 EPS by 1c

November 7, 2012 7:02 AM

Antares Pharma (NASDAQ: ATRS) reported Q3 EPS of ($0.03), $0.01 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found